Latest News and Events
Filter by
Selections
March 3, 2014
Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520
Read MoreFebruary 24, 2014
Arrowhead Closes Underwritten Offering with Gross Proceeds of $120 Million
Read MoreFebruary 20, 2014
Arrowhead to Present at RBC Capital Markets’ Global Healthcare Conference
Read MoreFebruary 4, 2014